EC Number   |
Title |
Organism |
|---|
   3.4.17.21 | Acetylation regulates the stability of glutamate carboxypeptidase II protein in human astrocytes |
Homo sapiens |
| 3.4.17.21 | Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II Synthesis and structural characterization |
Homo sapiens |
| 3.4.17.21 | Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities |
Homo sapiens |
| 3.4.17.21 | Design of composite inhibitors targeting glutamate carboxypeptidase II the importance of effector functionalities |
Homo sapiens |
| 3.4.17.21 | Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II |
Homo sapiens |
| 3.4.17.21 | Detection and quantitation of glutamate carboxypeptidase II in human blood |
Homo sapiens |
| 3.4.17.21 | Discovery of orally available prodrugs of the glutamate carboxypeptidase II (GCPII) inhibitor 2-phosphonomethylpentanedioic acid (2-PMPA) |
Canis lupus familiaris |
| 3.4.17.21 | Discovery of orally available prodrugs of the glutamate carboxypeptidase II (GCPII) inhibitor 2-phosphonomethylpentanedioic acid (2-PMPA) |
Mus musculus |
| 3.4.17.21 | Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats a role for N-acetylaspartylglutamate (NAAG) |
Rattus norvegicus |
| 3.4.17.21 | HDAC1 regulates the stability of glutamate carboxypeptidase II protein by modulating acetylation status of lysine 479 residue |
Homo sapiens |
